Arvinas Competitors and Similar CompaniesClear all
Lyell's competitors and similar companies include Foghorn Therapeutics and Stelexis Therapeutics.
 Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | |||
Founding Date | Founding Date 2018 | Founding Date 2016 | Founding Date 2017 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Cambridge, US HQ Cambridge, US | Locations New York, US HQ |
Employees | Employees 188 | Employees 16135% increase | Employees 3 |
Valuation ($) | Valuation ($) 243.3 m | Valuation ($) 452 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $130k (FY, 2023) | Revenue (est.) $34.2m (FY, 2023) | Revenue (est.) N/A |
Net income | Net income ($234.6m) (FY, 2023) | Net income ($98.4m) (FY, 2023) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 50m | Total funding raised $ 43m |
For sources of this data, please see the company profile
View Company Profiles
Foghorn Therapeutics
HQ
Cambridge, US
Employees
161↑ 35% increase
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company
Stelexis Therapeutics
HQ
New York, US
Employees
3
Stelexis Therapeutics is a cancer therapeutics company.
View company